Pfam Domains GO Terms
| CDC48 2 |
| CDC48 N |
| AAA 2 |
| AAA |
| Golgi vesicle docking |
| SNARE complex disassembly |
| positive regulation of receptor recycling |
| plasma membrane fusion |
| ATPase activity, coupled |
| regulation of receptor recycling |
| syntaxin-1 binding |
| ionotropic glutamate receptor binding |
| Golgi to plasma membrane protein transport |
| Golgi stack |
| dendritic shaft |
| establishment of protein localization to plasma membrane |
| Golgi to plasma membrane transport |
| vesicle docking |
| vesicle targeting, rough ER to cis-Golgi |
| COPII vesicle coating |
| SNARE binding |
| vesicle coating |
| COPII-coated vesicle budding |
| vesicle targeting, to, from or within Golgi |
| Golgi vesicle budding |
| retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum |
| PDZ domain binding |
| vesicle targeting |
| vesicle-mediated transport to the plasma membrane |
| vesicle budding from membrane |
| post-Golgi vesicle-mediated transport |
| membrane fusion |
| cellular protein complex disassembly |
| Rab GTPase binding |
| potassium ion transport |
| organelle localization by membrane tethering |
| establishment of vesicle localization |
| membrane docking |
| protein localization to plasma membrane |
| vesicle localization |
| endoplasmic reticulum to Golgi vesicle-mediated transport |
| positive regulation of protein catabolic process |
| regulation of exocytosis |
| protein localization to cell periphery |
| ATPase activity |
| protein-containing complex disassembly |
| postsynaptic density |
| establishment of protein localization to membrane |
| protein-containing complex binding |
| vesicle organization |
| lysosomal membrane |
| establishment of organelle localization |
| Golgi vesicle transport |
| regulation of protein catabolic process |
| cellular component disassembly |
| monovalent inorganic cation transport |
| positive regulation of catabolic process |
| protein kinase binding |
| protein localization to membrane |
| regulation of vesicle-mediated transport |
| organelle localization |
| Golgi membrane |
| metal ion transport |
| regulation of secretion by cell |
| exocytosis |
| regulation of secretion |
| cation transport |
| membrane organization |
| regulation of catabolic process |
| intracellular protein transport |
| secretion by cell |
| export from cell |
| secretion |
| ion transport |
| ATP binding |
| protein transport |
| intracellular transport |
| peptide transport |
| protein-containing complex assembly |
| amide transport |
| cellular protein localization |
| cellular macromolecule localization |
| establishment of protein localization |
| positive regulation of protein metabolic process |
| positive regulation of signaling |
| establishment of localization in cell |
| nitrogen compound transport |
| protein-containing complex subunit organization |
| regulation of transport |
| vesicle-mediated transport |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Screen | Score |
|---|---|
| Tanespimycin 14μM R08 exp527 | -2.49 |
| Vinblastine 0.015μM R05 exp208 | -2.16 |
| Deferoxamine 11μM R07 exp350 | -1.84 |
| Benzoate 20000μM R08 exp456 | -1.82 |
| UMK57 1μM R01 exp59 | -1.74 |
| SGC0649 7μM R03 exp150 | 1.97 |
| LB-100 2μM R05 exp210 | 2.37 |
| Gene | Correlation |
|---|---|
| HGC6.3 | 0.576 |
| TFIP11 | 0.529 |
| IK | 0.524 |
| UTP3 | 0.504 |
| DOCK6 | 0.501 |
| PSMB4 | 0.499 |
| COPG1 | 0.494 |
| RPS2 | 0.492 |
| COPA | 0.487 |
| POLR2J3 | 0.486 |
| ATP6V1B2 | 0.484 |
| CCNA2 | 0.484 |
| VPS28 | 0.482 |
| TCEB3CL2 | 0.475 |
| TYMS | 0.475 |
| TSPY8 | 0.473 |
| TCEB3C | 0.472 |
| TWISTNB | 0.469 |
| CHD4 | 0.468 |
| ZNF830 | 0.466 |
| TIMELESS | 0.466 |
| PSMB3 | 0.463 |
| GOSR2 | 0.462 |
| TINF2 | 0.462 |
| CBWD3 | 0.462 |
| RANBP2 | 0.462 |
| EXOSC6 | 0.461 |
| CBWD6 | 0.459 |
| EXOSC3 | 0.458 |
| TCEB3CL | 0.455 |
| CBWD5 | 0.455 |
| NARFL | 0.453 |
| NUPL1 | 0.451 |
| TICRR | 0.449 |
| C14orf93 | 0.447 |
| CACTIN | 0.446 |
| RPS12 | 0.446 |
| COPZ1 | 0.446 |
| ACSF2 | 0.444 |
| PSMC2 | 0.443 |
| NPIPB5 | 0.441 |
| C1QTNF9B | 0.441 |
| CCDC64B | 0.44 |
| ATP6V1C1 | 0.44 |
| ANKLE1 | 0.44 |
| RNPC3 | 0.44 |
| TRAPPC11 | 0.44 |
| TP53TG3 | 0.439 |
| TP53TG3B | 0.439 |
| EXOSC9 | 0.438 |
| TP53TG3C | 0.438 |
| NOP14 | 0.437 |
| AKIRIN2 | 0.437 |
| SCGB1C1 | 0.435 |
| PDCD7 | 0.435 |
| MT1E | 0.435 |
| CDC6 | 0.435 |
| NFATC4 | 0.434 |
| SF3A1 | 0.433 |
| SULT2B1 | 0.433 |
| PSMB2 | 0.431 |
| SLC4A1 | 0.43 |
| DISP2 | 0.43 |
| RPL6 | 0.428 |
| PSMA6 | 0.428 |
| PDCD11 | 0.428 |
| RPL35 | 0.427 |
| CTAGE9 | 0.427 |
| PSMB1 | 0.425 |
| RPL14 | 0.421 |
| TBC1D3H | 0.42 |
| ZFAND5 | 0.418 |
| RPL30 | 0.417 |
| PSMC5 | 0.416 |
| TBC1D3G | 0.416 |
| FAM231C | 0.415 |
| FAM231A | 0.415 |
| DDX47 | 0.415 |
| SNIP1 | 0.414 |
| EIF3G | 0.414 |
| SUPT5H | 0.414 |
| ORC6 | 0.413 |
| KCTD17 | 0.412 |
| FOXD4L2 | 0.411 |
| MEPCE | 0.411 |
| RPLP1 | 0.41 |
| CTAGE4 | 0.41 |
| SETD1A | 0.41 |
| KIF3C | 0.41 |
| NOL9 | 0.41 |
| TBC1D3F | 0.41 |
| XAB2 | 0.409 |
| NUP153 | 0.409 |
| DDTL | 0.408 |
| CDH24 | 0.408 |
| AAMP | 0.408 |
| WDR75 | 0.408 |
| RPS5 | 0.406 |
| KRT78 | 0.406 |
| MYO1H | 0.405 |
| RAD51 | 0.405 |
| CCDC94 | 0.405 |
| VASN | 0.404 |
| FAM25B | 0.403 |
| AKAP1 | 0.403 |
| COL2A1 | 0.402 |
| NUP160 | 0.402 |
| CHMP4B | 0.401 |
| GAR1 | 0.401 |
| POLR2D | 0.401 |
| CMYA5 | 0.4 |
| RRP1 | 0.4 |
| HIVEP3 | 0.4 |
| CDC45 | 0.4 |
| AKT1S1 | 0.4 |
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 1/1 |
| 909776.0 | 1/1 |
| bile duct | 27/28 |
| blood | 28/28 |
| bone | 26/26 |
| breast | 33/33 |
| central nervous system | 56/56 |
| cervix | 4/4 |
| colorectal | 17/17 |
| esophagus | 13/13 |
| fibroblast | 1/1 |
| gastric | 16/16 |
| kidney | 21/21 |
| liver | 20/20 |
| lung | 74/75 |
| lymphocyte | 16/16 |
| ovary | 26/26 |
| pancreas | 24/24 |
| peripheral nervous system | 16/16 |
| plasma cell | 15/15 |
| prostate | 1/1 |
| skin | 24/24 |
| soft tissue | 9/9 |
| thyroid | 2/2 |
| upper aerodigestive | 22/22 |
| urinary tract | 28/29 |
| uterus | 5/5 |
Expression Distribution